Ourania Tsitsilonis

About Ourania Tsitsilonis

Ourania Tsitsilonis, With an exceptional h-index of 32 and a recent h-index of 22 (since 2020), a distinguished researcher at National and Kapodistrian University of Athens, specializes in the field of Immunology, Cancer Immunotherapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatin

Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma

Unraveling the Role of the NLRP3 Inflammasome in Lymphoma: Implications in Pathogenesis and Therapeutic Strategies

Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic …

Low Levels of Circulating Tumor Cells Correlate with Favorable Clinical Outcome and Unique Biological Features in Newly Diagnosed Multiple Myeloma Patients

Impact of daratumumab on stem cell mobilization and collection, engraftment and early post-transplant complications among multiple myeloma patients undergoing autologous stem …

Myelodysplastic Syndrome Red Blood Cell Physiology Abnormalities and Their Correlation with Disease Risk and Therapeutic Interventions

Empagliflozin restores the deregulated cardiac endothelial cell transcriptome in vivo upon myocardial ischemia reperfusion injury and reduces the infiltration of immune cells

Ourania Tsitsilonis Information

University

Position

Department of Biology

Citations(all)

3603

Citations(since 2020)

1827

Cited By

2263

hIndex(all)

32

hIndex(since 2020)

22

i10Index(all)

75

i10Index(since 2020)

45

Email

University Profile Page

Google Scholar

Ourania Tsitsilonis Skills & Research Interests

Immunology

Cancer Immunotherapy

Top articles of Ourania Tsitsilonis

Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatin

Basic Research in Cardiology

2024/3/23

Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma

2024/2/26

Unraveling the Role of the NLRP3 Inflammasome in Lymphoma: Implications in Pathogenesis and Therapeutic Strategies

2024/2/17

Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic …

Blood Cancer Journal

2024/2/6

Low Levels of Circulating Tumor Cells Correlate with Favorable Clinical Outcome and Unique Biological Features in Newly Diagnosed Multiple Myeloma Patients

Blood

2023/11/28

Impact of daratumumab on stem cell mobilization and collection, engraftment and early post-transplant complications among multiple myeloma patients undergoing autologous stem …

Leukemia & Lymphoma

2023/11/10

Myelodysplastic Syndrome Red Blood Cell Physiology Abnormalities and Their Correlation with Disease Risk and Therapeutic Interventions

Blood

2023/11/2

Ourania Tsitsilonis
Ourania Tsitsilonis

H-Index: 18

Marianna Antonelou
Marianna Antonelou

H-Index: 21

Empagliflozin restores the deregulated cardiac endothelial cell transcriptome in vivo upon myocardial ischemia reperfusion injury and reduces the infiltration of immune cells

European Heart Journal

2023/11

Establishment of an in vivo murine model of immune checkPoint inhibitors cardiotoxicity: emerging role of vascular permeability in pembrolizumab-induced cardiotoxicity

European Heart Journal

2023/11

Non-Traditional Cardiovascular Risk Factors in Adolescents with Obesity and Metabolic Syndrome May Predict Future Cardiovascular Disease

Nutrients

2023/10/12

OA-14 Persistent bone marrow and imaging MRD negativity may guide the duration of lenalidomide maintenance following ASCT in patients with multiple myeloma

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

OA-13 Increased levels of circulating tumor cells correlate with adverse clinical outcomes and distinct biological features in newly diagnosed patients with multiple myeloma

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets

2023/8/4

P834: MULTIPARAMETRIC FLOW CYTOMETRY FOR THE DETECTION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH IGM MONOCLONAL GAMMOPATHIES

HemaSphere

2023/8/1

P861: persistent bone marrow and imaging MRD negativity AS criteria to stop lenalidomide maintenance following ASCT: preliminary results of a single-center prospective cohort study

HemaSphere

2023/8/1

PB2124: EFFICACY AND IMMUNE MODULATION OF DARATUMUMAB PLUS IMID COMBINATION IN PATIENTS REFRACTORY TO BOTH AGENTS “

HemaSphere

2023/8/1

Microtubule dynamics deregulation induces apoptosis in human urothelial bladder cancer cells via a p53-independent pathway

Cancers

2023/7/22

B06 HIGH LEVELS OF CIRCULATING PLASMA CELLS AT DIAGNOSIS ARE PREDICTIVE FOR WORSE PROGNOSIS IN BOTH TRANSPLANT-ELIGIBLE AND-INELIGIBLE PATIENTS WITH MULTIPLE MYELOMA

HemaSphere

2023/5/1

Short term starvation potentiates the efficacy of chemotherapy in triple negative breast cancer via metabolic reprogramming

Journal of Translational Medicine

2023/3/3

Belantamab mafodotin induces immunogenic cell death within 24 h post-administration in newly diagnosed multiple myeloma patients

American journal of hematology

2023/3

Ourania Tsitsilonis
Ourania Tsitsilonis

H-Index: 18

Evangelos Terpos
Evangelos Terpos

H-Index: 61

See List of Professors in Ourania Tsitsilonis University(National and Kapodistrian University of Athens)